These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38729501)

  • 1. The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses.
    El-Fakharany EM; El-Gendi H; Saleh AK; El-Sayed MH; Alalawy AI; Jame R; Abdelaziz MA; Alshareef SA; El-Maradny YA
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132254. PubMed ID: 38729501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Peptides--a new strategy for combating viral infections].
    Kołodziej M; Joniec J; Bartoszcze M; Mirski T; Gryko R
    Przegl Epidemiol; 2011; 65(3):477-82. PubMed ID: 22184952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins.
    Tan H; Su W; Zhang W; Wang P; Sattler M; Zou P
    Curr Pharm Des; 2018; 24(41):4932-4946. PubMed ID: 30727869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Update on Strategies to Deliver Protein and Peptide Drugs to the Eye.
    Boddu SHS; Acharya D; Hala V; Jani H; Pande S; Patel C; Shahwan M; Jwala R; Ranch KM
    ACS Omega; 2023 Oct; 8(39):35470-35498. PubMed ID: 37810716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isopeptide Bond Bundling Superhelix for Designing Antivirals against Enveloped Viruses with Class I Fusion Proteins: A Review.
    Na H; Liang G; Lai W
    Curr Pharm Biotechnol; 2023; 24(14):1774-1783. PubMed ID: 37005549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of biopharmaceutical proteins by yeast: advances through metabolic engineering.
    Nielsen J
    Bioengineered; 2013; 4(4):207-11. PubMed ID: 23147168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses.
    Sukmarini L
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35565968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering growth factors for regenerative medicine applications.
    Mitchell AC; Briquez PS; Hubbell JA; Cochran JR
    Acta Biomater; 2016 Jan; 30():1-12. PubMed ID: 26555377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceuticals in China.
    Hu X; Ma Q; Zhang S
    Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ growth of a C-terminal interferon-alpha conjugate of a phospholipid polymer that outperforms PEGASYS in cancer therapy.
    Hu J; Wang G; Zhao W; Gao W
    J Control Release; 2016 Sep; 237():71-7. PubMed ID: 27393654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Enzymes: Applications and Approaches to Pharmacological Improvement.
    Yari M; Ghoshoon MB; Vakili B; Ghasemi Y
    Curr Pharm Biotechnol; 2017; 18(7):531-540. PubMed ID: 28786356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase.
    Gale M; Katze MG
    Pharmacol Ther; 1998 Apr; 78(1):29-46. PubMed ID: 9593328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral RNA capping: Mechanisms and antiviral therapy.
    Chen S; Jiang Z; Li Q; Pan W; Chen Y; Liu J
    J Med Virol; 2024 May; 96(5):e29622. PubMed ID: 38682614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide-Based Antiviral Drugs.
    Murugan NA; Raja KMP; Saraswathi NT
    Adv Exp Med Biol; 2021; 1322():261-284. PubMed ID: 34258744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress towards recombinant anti-infective antibodies.
    Pai JC; Sutherland JN; Maynard JA
    Recent Pat Antiinfect Drug Discov; 2009 Jan; 4(1):1-17. PubMed ID: 19149692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of potent long-lasting consensus interferon using albumin fusion technology in Pichia pastoris expression system.
    Naseem MU; Ahmed N; Khan MA; Tahir S; Zafar AU
    Protein Expr Purif; 2020 Feb; 166():105509. PubMed ID: 31604114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco - a producer of recombinant interferons.
    Budzianowski J
    Przegl Lek; 2014; 71(11):639-43. PubMed ID: 25799861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors involved in heterologous expression of proteins in E. coli host.
    Pouresmaeil M; Azizi-Dargahlou S
    Arch Microbiol; 2023 Apr; 205(5):212. PubMed ID: 37120438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-immunogenicity relationships of therapeutic proteins.
    Hermeling S; Crommelin DJ; Schellekens H; Jiskoot W
    Pharm Res; 2004 Jun; 21(6):897-903. PubMed ID: 15212151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.